The DPP-4 inhibitors are a widely used class of drug to help manage blood glucose levels in patients with type 2 diabetes. But how were they discovered? In the following presentation, Dr Edwin Villhauer describes the journey he took with Novartis to discover vildagliptin, the first DPP-4 inhibitor.
Diabetes and hypertension are closely related. In this animation, the benefits of effective hypertension management in patients with diabetes are reviewed.
Alternatively login via
Back to epgonline.org